Arzan Wealth Advises on the Strategic Acquisition of a Premier Radiology Center Portfolio in Long Island, New York

  Dubai, United Arab Emirates - Thursday, 20. March 2025 AETOSWire  

Arzan Wealth (DIFC) Limited (‘Arzan Wealth’), a Dubai-based advisory firm regulated by the Dubai Financial Services Authority, is delighted to announce its successful advisory role in the acquisition of a portfolio of three outpatient imaging centers in Nassau County, Long Island, New York, USA.

The centers operate under the name Lenox Hill Radiology, a wholly owned subsidiary of RadNet (Nasdaq: RDNT | S&P: B+), one of the largest outpatient diagnostic imaging providers in the U.S. These state-of-the-art facilities, totaling 29,283 square feet, are strategically located along major thoroughfares, providing excellent visibility and easy access for patients. Fully leased for 16 years with a 3% annual indexation, the centers are operated by one of the region's most dominant radiology practices.

Arzan Wealth provided comprehensive advisory services throughout the structuring and acquisition process, ensuring a seamless transaction. The firm will continue to advise on the investment during the holding period, which is expected to generate an average net cash yield payment of 8.5% over the anticipated 5-year holding period.

Muhannad Abulhasan, CEO of Arzan Wealth, commented:

"We are excited to have successfully facilitated the acquisition of this strategic portfolio of outpatient imaging centers. This investment aligns with our commitment to identifying high-quality, income-generating assets for our clients. The portfolio's long-term leases and strong tenant profile provide stability, while the projected cash yield of 8.5% over the next five years offers an attractive current income portion of the total return. We continue to prioritize prudent risk management, ensuring that our clients' wealth is safeguarded while generating robust financial outcomes for the long term."

Notes to Editors

About Arzan Wealth (DIFC) Limited

Arzan Wealth is an investment advisory firm registered at the Dubai International Financial Centre (DIFC), and is regulated by the Dubai Financial Services Authority (DFSA). Arzan Wealth currently advises various professional clients on real estate, private equity and other investments with a total value of assets advised around US$ 2.57 Billion.  Arzan Wealth focuses on arranging yielding investments in major global markets, as well as bespoke investments that meet the requirements of specific clients.

Past or projected performance is not necessarily a reliable indicator of future results. Arzan Wealth (DIFC) Limited accepts no liability for any loss arising from the use of this document or its contents or otherwise arising in connection therewith.

Permalink

https://www.aetoswire.com/en/news/2003202545487

Contacts

For further information contact:

Ahmad AlSabbrei

Head of Investment Operations

a.alsabbrei@arzanwealth.com

+965 9988 8624

Experian Assistant Wins 2025 FinTech Breakthrough Award for Analytics Innovation

 Agentic AI-powered virtual assistant offers 24/7 analytics and modeling expertise, helps slash model-development times for financial institutions

 

(BUSINESS WIRE)--Experian, a leading global data and technology company, today announced that Experian Assistant, an agentic AI-powered solution that greatly accelerates the data-modeling lifecycle, has won the 2025 FinTech Breakthrough Award for Analytics Innovation. For the second consecutive year, Experian received this prestigious award that recognizes those “who are dedicated to reshaping the FinTech industry and improving people’s lives through innovative technologies.”

Experian Assistant enables financial institutions to perform data exploration, build and deploy models, monitor their performance, and increase speed to market to launch new offerings. Integrated with Experian Ascend Platform™, the solution greatly accelerates the modeling lifecycle, slashing model-development times from months to days and — in some cases — hours.

“To stay ahead of their competition, financial institutions need a solution to quickly go from ideas to data and into production,” said Shri Santhanam, Executive Vice President and General Manager of Software, Platforms, and AI, Experian North America. “Like having an analytics and modeling expert by your side 24x7, Experian Assistant provides immediate responses to users’ questions, enhances model transparency, and helps quickly parse through multiple model iterations by selecting optimal modeling features along with coding and deployment support.”

The world’s largest financial Institutions use Experian’s Ascend Platform and – in close collaboration with several customers – Experian Assistant was developed to offer them a deeper understanding of credit data and provide best practices on how to optimally use analytics. It enables those institutions to broaden their scope of data and deploy advanced, agentic AI to effectively score a larger number of consumers. This improves their accuracy and inclusivity, and aligns with Experian's mission of fostering greater financial equity.

Experian Assistant advances regulatory compliance through automated model risk documentation, identity and fraud management, risk assessment and transaction monitoring.

This year’s 9th annual awards program received more than 4,500 nominations from all over the world. For more information on the 2025 FinTech Breakthrough Awards, visit: https://fintechbreakthrough.com/.

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agribusiness, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250320296728/en/

Permalink

https://www.aetoswire.com/en/news/2003202545517

Contacts

Michael Troncale

Experian Public Relations

+1 714 830 5462

michael.troncale@experian.com

SoftBank Group to Acquire Ampere Computing

TOKYO & SANTA CLARA, Calif. - Thursday, 20. March 2025

(BUSINESS WIRE)--SoftBank Group Corp. (TSE: 9984, “SoftBank Group”) today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere’s lead investors – Carlyle (NASDAQ: CG) and Oracle Corp. (NYSE: ORCL) – are selling their respective positions in Ampere.

As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group’s capabilities in key areas and accelerate its growth initiatives.

“The future of Artificial Super Intelligence requires breakthrough computing power,” said Masayoshi Son, Chairman and CEO of SoftBank Group Corp. “Ampere’s expertise in semiconductors and high-performance computing will help accelerate this vision, and deepens our commitment to AI innovation in the United States.”

“With a shared vision for advancing AI, we are excited to join SoftBank Group and partner with its portfolio of leading technology companies,” said Renee James, Founder and CEO of Ampere. “This is a fantastic outcome for our team, and we are excited to drive forward our AmpereOne® roadmap for high performance Arm processors and AI.”

Founded in Silicon Valley in 2018 with an initial focus on cloud-native computing, Ampere has since expanded into sustainable AI compute. The company has multiple products for a spectrum of cloud workloads from the edge to the cloud data center.

Transaction Details

Under the terms of the agreement, SoftBank will acquire Ampere for $6.5 billion in cash. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the second half of 2025. Ampere’s headquarters will remain in Santa Clara, CA.

About SoftBank Group

The SoftBank Group invests in breakthrough technology to improve the quality of life for people around the world. The SoftBank Group is comprised of SoftBank Group Corp. (TOKYO: 9984), an investment holding company that includes stakes in AI, smart robotics, IoT, telecommunications, internet services, and clean energy technology providers, as well as a majority stake in Arm, which is building the future of computing; and the SoftBank Vision Funds, which are investing to help transform industries and shape new ones. To learn more, please visit https://group.softbank/en.

About Ampere

Ampere is a semiconductor design company focused on high-performance, energy efficient, sustainable AI Compute based on the Arm compute platform. To learn more, please visit https://amperecomputing.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319660334/en/

Permalink

https://www.aetoswire.com/en/news/2003202545491

Contacts

Media contacts:

Ampere

press@amperecomputing.com

SoftBank Group

softbank@fgsglobal.com

Venture Global Receives Non-FTA Export Authorization for CP2 LNG

 U.S. Department of Energy grants CP2 LNG approval to export to non-FTA countries

(BUSINESS WIRE) -- Today, Venture Global received approval from the U.S. Department of Energy to export liquefied natural gas (LNG) to non-FTA countries for its third project, CP2 LNG, located in Cameron Parish, Louisiana. Venture Global CEO Mike Sabel issued the following statement:

“CP2 LNG is a vital project for the U.S. economy, balance of trade, and global energy security. We are grateful for the Trump Administration’s return to regular order and regulatory certainty that will allow us to further expand U.S. LNG exports, which have consistently been found to be in the public interest across multiple Administrations. This will enable us to provide our allies around the world with American LNG in just a few years and for decades to come.”

Earlier this month, Venture Global announced that it has launched the FID process for CP2 LNG. To date, the initial phase of CP2 LNG has been sold through 20-year sales and purchase agreements with ExxonMobil, Chevron, JERA, New Fortress Energy, INPEX, China Gas, SEFE and EnBW. Venture Global is in active discussions for the remaining capacity and has launched significant off site construction of the project while it has awaited project authorizations from U.S. regulators.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319226258/en/

Permalink

https://www.aetoswire.com/en/news/1903202545485

Contacts

Investor Contact

Michael Pasquarello

IR@ventureglobalLNG.com

Media Contact

Shaylyn Hynes

press@ventureglobalLNG.com

 

Fujirebio Enhances Supply Chain Operations with Kinaxis

 OTTAWA, Ontario -

Japanese biotech leader adopts orchestration to more rapidly respond to demand fluctuations

(BUSINESS WIRE) -- Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Fujirebio Inc., a Japanese multinational biotechnology company, is using Kinaxis and its AI-powered supply chain orchestration platform Maestro™ to enhance and optimize its supply chain operations.

Fujirebio Inc., a consolidated subsidiary of Fujirebio Holdings Inc., is a global leader in the development, manufacturing and sales of clinical diagnostic reagents and testing equipment. Fujirebio is currently focused on strengthening and expanding its Contract Development and Manufacturing Organization (CDMO) by leveraging high-quality raw materials in the immunology field and advanced reagent development technologies.

To accelerate the company’s growth, Fujirebio needed to strategically link and synchronize its entire supply chain process, which spans raw material production to final product shipment and encompasses a multi-layered and complex set of operations.

“The adoption of Kinaxis is central to building a more flexible and efficient supply chain model,” said Kazuya Saito, division head of SCM division, corporate SCM division at Fujirebio Inc. “This will enable faster strategic decision-making and accelerate our efforts toward transforming our business structure. At the same time, we aim to provide new value to the healthcare industry.”

By implementing the Maestro platform, Fujirebio is working to orchestrate demand, production and procurement planning across its supply chain, enabling fast planning simulations. This will also facilitate the establishment of an S&OP (Sales and Operations Planning) process that accelerates strategic decision-making based on financial data.

“In the healthcare industry, there is a need for advanced planning management that considers manufacturing constraints and manages inventory in both quantity and financial terms. We are pleased to support Fujirebio as they advance strategic decision-making through the use of simulations,” said Phillip Teschemacher, president of APAC at Kinaxis.

To learn more about Kinaxis and its supply chain orchestration solutions, please visit Kinaxis.com.

About Fujirebio

Fujirebio, a member of H.U. Group Holdings Inc., is a global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value partnerships with other leading companies in the industry, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms. For more information about Fujirebio, please visit www.fujirebio.com.

About Kinaxis

Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Source: Kinaxis Inc.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319567981/en/

Permalink

https://www.aetoswire.com/en/news/1903202545479

Contacts

Media Relations

Matt Tatham | Kinaxis

mtatham@kinaxis.com

+1 917.446.7227

Investor Relations

Rick Wadsworth | Kinaxis

rwadsworth@kinaxis.com

+1 613-907-7613

 

Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy

 GENT, Belgium

(BUSINESS WIRE)--Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro diagnostic use, designed for the qualitative detection and identification of Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes a and b of genotype 1 in human serum or EDTA plasma samples. Additional subtype information is available in a majority of cases.

“At Fujirebio we have been pioneering molecular testing solutions since the 1990’s with our high quality LiPA platform,” says Christiaan De Wilde, CEO at Fujirebio Europe. “The historical VERSANT HCV Genotype 2.0 Assay (LiPA) served as an efficient aid to personalized HCV therapy, and we are very pleased to maintain the availability of the test, now officially a part of our INNO-LiPA product range. We would like to extend our gratitude to all INNO-LiPA customers for their continued trust.”

About Hepatitis C virus

Hepatitis C virus is one of the leading causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma (primary liver cancer), resulting in major global public health concerns. The HCV infection is unevenly distributed worldwide, with variations in prevalence across and within countries.1

Globally, an estimated 50 million people have chronic hepatitis C virus infection, with about 1.0 million new infections occurring per year. WHO estimated that in 2022, approximately 242 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma. Early detection and treatment can prevent serious liver damage and improve long-term health.2

About INNO-LiPA HCV 2.0 Genotyping

INNO-LiPA HCV 2.0 Genotyping products are IVDR-marked. The available* products are:

INNO-LiPA HCV 2.0 Genotyping <20T,CE> (Cat# 81547)

INNO-LiPA HCV 2.0 Amp <20T,CE> (Cat# 81548)

INNO-LiPA HCV 2.0 Control <3T,CE> (Cat# 81549)

LiRAS® for LiPA HCV v4 (Cat# 15228)

The assay is available in a size of 20T. The test can be performed manually or automated (on the TENDIGO™ (Cat# 80412) instrument) and is not intended to be used as a screening test for HCV or as a diagnostic test to confirm the presence of HCV.

Visit www.fujirebio.com for more information about this product.

* Please contact Fujirebio for further information about the local availability of the test.

References:

Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel MK, Razzack AA, Solimando AG, Thompson A, Andrews, K, Enebong Nya G, Ahmad S, Ranaldo R, Cozzolongo R, Shahini E. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):637-656. doi: 10.51821/84.4.015. PMID: 34965046.

https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250317463658/en/

Permalink

https://www.aetoswire.com/en/news/20250317463658r1

Contacts

 

For media:

Public Relations Section, Public Relations/Sustainability Department,

H.U. Group Holdings, Inc..

Phone: +81-3-6279-0884

E-mail: pr@hugp.com

Christiaan De Wilde

CEO Fujirebio Europe

Phone: +32 9329 1703

For investors and analysts:

IR/SR Dept.

Phone: +81-3-5909-3337

E-mail: ir@hugp.com

Accelera hosts Spanish Prime Minister and industry leaders for tour and meeting at Guadalajara electrolyzer facility

GUADALAJARA, Spain - Wednesday, 19. March 2025

(BUSINESS WIRE)--Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], hosted Spanish Prime Minister Pedro Sánchez and other government officials at its state-of-the-art electrolyzer manufacturing facility in Guadalajara, Castilla-la Mancha, Spain. The visit highlighted Accelera's important role in enabling the European Union (EU) and Spain's energy transition toward a sustainable future. Following Prime Minister Sánchez’s visit, Accelera held a meeting with top industry executives to explore opportunities for advancing the Spanish green hydrogen market together.

The Government of Spain is committed to the green transition, with green hydrogen as one of its pillars. The decisive policies promoted by the Executive have allowed 20% of green hydrogen projects in Europe to be promoted in Spain.

Prime Minister Sánchez toured the 260,000 square-foot proton exchange membrane (PEM) electrolyzer manufacturing facility, one of the largest in Spain, and met with Accelera employees to celebrate their work in building the nation’s green hydrogen economy. The energy-efficient electrolyzer facility began production in April 2024 and has created 91 highly skilled jobs, with the potential for more as production expands.

Accelera is one of Spain’s leading electrolyzer manufacturers, and with one of the largest economies in the EU and its low cost of renewable energy, the country offers a strong environment for the expansion of hydrogen and electrolyzer production and export.

"We are honored to have Prime Minister Pedro Sánchez visit Accelera’s electrolyzer manufacturing plant in Guadalajara,” said Amy Davis, President of Accelera. “Our partnership with the Spanish government is key to developing the necessary infrastructure to continue scaling and innovating hydrogen technologies to achieve a zero-emissions future. Together, we are committed to advancing Spain and the EU’s green energy transition.”

Accelera recently announced its largest electrolyzer project to date – a 100-megawatt (MW) system for bp’s green hydrogen plant in Lingen, Germany – and production for the electrolyzer system is underway at the facility in Guadalajara. With an immediate 500MW of capacity, scalable to 1-gigawatt (GW), Accelera has plans to increase onsite manufacturing in the future, bringing more hydrogen production to Spain and further establishing the country as a hydrogen industrial hub in Europe.

After the Prime Minister’s visit, Accelera hosted a high-level meeting with Spain’s green hydrogen leaders to explore collaboration opportunities to accelerate Spain's position as Europe's hydrogen hub and meet the ambitious decarbonization targets set by both the country and the EU. This dialogue focused on establishing a framework for ongoing industry partnership to maximize Spain's ability to be a leader in green hydrogen production and technology development.

During the discussions, participants emphasized the importance of domestic electrolyzer production in Spain, including Accelera’s plant in Guadalajara. This production is crucial not only for reaching Spain’s target of 12 GW of installed electrolyzers, but also for creating jobs and strengthening Spain’s industrial base.

Attendees included:

    Olvido Moraleda, President of bp Spain and Vice President of bp group
    Arturo Gonzalo Aizpiri, CEO of Enagás
    Millán García-Tola, Global Hydrogen Director of Iberdrola
    José Manuel Martínez, CTO of Moeve
    Amy Davis, President of Accelera by Cummins
    Andreas Lippert, Vice President of Electrolyzers for Accelera by Cummins

Electrolyzers leverage renewable energy sources to produce green hydrogen, which is vital for accelerating the clean energy transition. Accelera is a leader in large-scale hydrogen production using PEM electrolysis and has deployed more than 600 electrolyzer units worldwide, powering some of the most advanced PEM electrolyzer systems operating globally. This includes a 20MW facility in Quebec, Canada, and a 25MW system in Florida, U.S.

###

About Accelera™ by Cummins

Accelera by Cummins provides a diverse portfolio of zero-emissions solutions for the world’s most economically vital industries, empowering them to accelerate the transition to a sustainable future. Accelera, a business segment of Cummins Inc., is both a components supplier and integrator, focused on batteries, e-axles, traction systems, integrated powertrain solutions, hydrogen fuel cells, and electrolyzers. Accelera currently has operations in North America, across Europe, and in China.

Cummins, a global power solutions leader, is a corporation of complementary business segments that design, manufacture, distribute, and service a broad portfolio of power solutions. Headquartered in Columbus, Indiana (U.S.), Cummins has approximately 69,900 employees and earned $3.9 billion on sales of $34.1 billion in 2024. It operates a robust distribution and support network in more than 190 countries and territories.

To learn more about Accelera by Cummins, visit accelerazero.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250318352856/en/

Permalink
https://www.aetoswire.com/en/news/20250318352856r1

Contacts
 

Melinda Koski – Director, External Communications
melinda.koski@cummins.com
+1-812-377-0500